Kennedy MC, Kerr T Overdose prevention in the United States: a call for supervised injection sites Am J Public Health, 2017. PubMed


Tran M, Wood E, Kerr T, Patterson S, Bangsberg D, Dong H, Guillemi S, Montaner JSG, Milloy MJ Increases in CD4+ cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada Antivir Ther, 2017. PubMed


Luongo N, Dong H, Kerr T, Milloy MJ, Hayashi K, Richardson L Income generation and attitudes towards addiction treatment among people who use illicit drugs in a Canadian setting Addict Behav, 2017. PubMed


Nolan S, Klimas J, Wood E Alcohol use in opioid agonist treatment Addict Sci Clin Pract, 2016. PubMed


Socías ME, Ahamad K An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders CMAJ, 2016. PubMed


Socías ME, Volkow N, Wood E Adopting the ‘cascade of care’ framework: an opportunity to close the implementation gap in addiction care? Addiction, 2016. PubMed


Zivanovic R, Wood E, Nolan S Naloxone infusion in the setting of an unknown ingestion: a case report Can J Addict, 2016. Link


Rieb LM, Norman WV, Martin RE, Berkowitz J, Wood E, McNeil R, Milloy MJ Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon Pain, 2016. PubMed


Lake S, Milloy MJ, Dong H, Hayashi K, Wood E, Kerr T, DeBeck K Initiation into prescription opioid injection and associated trends in heroin use among people who use illicit drugs Drug Alcohol Depend, 2016. PubMed


Krebs E, Wang L, Olding M, DeBeck K, Hayashi K, Milloy MJ, Wood E, Nosyk B, Richardson L Increased drug use and the timing of social assistance receipt among people who use illicit drugs Soc Sci Med, 2016. PubMed